Alector (ALEC) Debt to Equity (2024 - 2026)
Alector (ALEC) reported Debt to Equity of $0.94 for Q1 2026, up 840.46% year-over-year from $0.1 in Q1 2025, and up 197.59% quarter-over-quarter from $0.32 in Q4 2025.
Alector (ALEC) Debt to Equity (2024 - 2026) Analysis & Trends
Alector (ALEC) has 3 years of Debt to Equity data on file, last reported at $0.94 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.94, up 840.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.94 (up 840.46% YoY), and the FY2025 annual result was $0.32, up 326.94% from the prior year.
- Debt to Equity rose to $0.94 in Q1 2026 per ALEC's latest filing, from $0.32 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.94 in Q1 2026 and troughed at $0.07 in Q4 2024.
- A 3-year average of $0.29 and a median of $0.15 in 2025 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2025 and 2026: Debt to Equity surged 326.94% in 2025, then surged 840.46% in 2026.
- A 3-year view of Debt to Equity shows it stood at $0.07 in 2024, then surged by 326.94% to $0.32 in 2025, then soared by 197.59% to $0.94 in 2026.
- Business Quant data shows ALEC's Debt to Equity at $0.94 in Q1 2026, $0.32 in Q4 2025, and $0.17 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 0.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 0.32 |
| Sep 30, 2025 | 0.17 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | 0.07 |